Secondary Hemostasis Flashcards
(89 cards)
Requirements of ACT coagulation test
Whole Blood
Contact Activator
Significance of prolonged Thrombin Time
Quantitative or qualitative abnormalities of fibrinogen
Inhibitors of fibrin formation
_______________ is required for the initation of secondary hemostasis when initiated by wounds
Tissue Factor
Result of Disseminated Intravascular Coagulation (DIC)
Thrombosis of the microvasculature
Depletion of coagulation factors and platelets → bleeding
Significance of prolonged PT
Factor VII deficiency
Deficiency or inhibition of common pathway factor
Inhibitor Consumption Tests
Antithrombin (AT)
Requirements for PT coagulation test
Citrated plasma
Tissue factor
Calcium
Platelet substitute
Cause of Disseminated Intravascular Coagulation (DIC)
Continued activation of coagulation and fibrinolysis
Induction or exposure of tissue factor or other activators of coagulation
Endothelial damage exposing collagen
Proteolytic enzymes
Stagnant blood flow
Increased concentration of D-Dimers occurs wtih
Increased fibrinolysis
Severe internal hemorrhage with fibrinolysis
Decreased clearance of FDP by liver
Coagulation test for the common pathway
Fibrinogen
TT
Tissue Factor Pathway Inhibitor inhibits
Generation of Xa
Loads of thrombin generated on the platelet surface drives the formation of
Fibrin
Thromibin time measures
Time for fibrin clot formation in citrated plasma + thrombin
Inhibitors of coagulation
Antithrombin
Activated Protein C (APC)
Tissue Factor Pathway Inhibitor (TFPI)
Alpha-2 Macroglobulin
Significance of fibrinogen concentration increase
Inflammation
Relative increase with dehydration
Two phases of DIC
Hypercoagulabile Phase
Consumptive Phase
Steps of the Common Pathway of the Coagulation Cascade
- X → Xa
- Prothrombin → Thrombin by Xa
- Fibrinogen → Fibrin by Thrombin
Vitamin K dependent Factors?
II, VII, IX, X
Categories of coagulation tests
Procoagulant Tests
Anticoagulat Tests
PIVKA would be increased in
Vitamin k antagonism/deficiency
Human hepatocellular carcinomas
Hypercoagulable Phase of DIC
Thrombosis
Ischemic necrosis and organ dysfunction
Prothrombin Time (PT) measures
Time for fibrin clot formation in citrated plasma + tissue factor + calcium + platelet phospholipid substitute
Clinical signs of DIC
Associated with the signs of primary disease
Signs of organ dysfunction secondary to thrombosis
Bleeding
Requirements of aPTT coagulation test
Citrated Plasma
Contact activator
Calcium
Platelet substitute